Showing results (541-550 of 554) with videos related to

Sort By:
Pageof 56
Nature Medicine|June 6, 2018
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinomaDavid F McDermott, Mahrukh A Huseni, Michael B Atkins, et al.
The New England Journal of Medicine|September 12, 2017
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV MelanomaJeffrey Weber, Mario Mandala, Michele Del Vecchio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2021
The State of Melanoma: Emergent Challenges and OpportunitiesMichael B Atkins, Clara Curiel-Lewandrowski, David E Fisher, et al.
BMC Cancer|March 23, 2023
Impact of COVID-19 in patients on active melanoma therapy and with history of melanomaDouglas B Johnson, Michael B Atkins, Cassandra Hennessy, et al.
Biorxiv : the Preprint Server for Biology|August 1, 2025
Pan-cancer prediction of tumor immune activation and response to immune checkpoint blockade from tumor transcriptomics and histopathologySumit Mukherjee, Sumeet Patiyal, Lipika R Pal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2022
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134Michael B Atkins, Sandra J Lee, Bartosz Chmielowski, et al.
Pigment Cell & Melanoma Research|April 19, 2016
The state of melanoma: challenges and opportunitiesGlenn Merlino, Meenhard Herlyn, David E Fisher, et al.
CA: a Cancer Journal for Clinicians|June 16, 2022
An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinomaElshad Hasanov, Debra Nana Yeboa, Mathew D Tucker, et al.
CA: a Cancer Journal for Clinicians|December 13, 2025
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancersRana R McKay, Sumanta Pal, Wanling Xie, et al.
Nature Communications|February 6, 2021
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinomaZiad Bakouny, David A Braun, Sachet A Shukla, et al.
Pageof 56